Akebia Therapeutics (AKBA) Shares Outstanding (2013 - 2026)
Akebia Therapeutics (AKBA) Shares Outstanding (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Akebia Therapeutics | 325.80 Mn | 163.20 Mn | 41.25 Mn | 267.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 267.05 Mn |
| Dec 31, 2025 | 257.16 Mn |
| Sep 30, 2025 | 264.79 Mn |
| Jun 30, 2025 | 262.57 Mn |
| Mar 31, 2025 | 235.50 Mn |
| Dec 31, 2024 | 210.95 Mn |
| Sep 30, 2024 | 210.35 Mn |
| Jun 30, 2024 | 209.71 Mn |
| Mar 31, 2024 | 204.96 Mn |
| Dec 31, 2023 | 187.47 Mn |
| Sep 30, 2023 | 188.31 Mn |
| Jun 30, 2023 | 186.82 Mn |
| Mar 31, 2023 | 184.77 Mn |
| Dec 31, 2022 | 182.78 Mn |
| Sep 30, 2022 | 183.88 Mn |
| Jun 30, 2022 | 183.60 Mn |
| Mar 31, 2022 | 179.60 Mn |
| Dec 31, 2021 | 165.95 Mn |
| Sep 30, 2021 | 173.78 Mn |
| Jun 30, 2021 | 161.33 Mn |